Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT05524012

Longitudinal Multimodal Response Assessment During Neoadjuvant Treatment of Rectal Cancer

Planning Adaptive Treatment by Longitudinal Response Assessment Implementing MR Imaging, Liquid Biopsy and Analysis of Microenvironment During Neoadjuvant Treatment of Rectal Cancer (PRIMO)

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
40 (estimated)
Sponsor
Jena University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This pilot study aims to trial multimodal early response assessment to enable therapy adaptions in the context of non-operative therapy strategies of locally advanced rectal cancer (LARC) for development of a non-invasive response prediction model.

Detailed description

Patients with LARC, receiving neoadjuvant chemoradiotherapy (CRT) are followed by at least 4 multiparametric MRI-scans (diffusion weighted imaging and hypoxia-sensitive sequences) as well as repeated blood samples in order to analyse circulating tumour cells (CTCs). A standard pelvis radiotherapy (RT, 5040 cGy) will be performed in combination with a 5-Fluorouracil / Oxaliplatin regimen in all patients (planned: N = 50), succeeded by consolidation CTx (FOLFOX4) if feasible. Additional histologic markers, such as tumour-infiltrating lymphocytes (TILs) or PD-L1 status will be analysed before and after CRT. Resection is standard after completion of preoperative treatment. In case of complete regression and patient's request, a non-operative management ("watch and wait") is offered alternatively. The primary endpoint is response, defined by tumor regression grading, secondary endpoints comprise longitudinal changes in MRI as well as in CTCs and TILs.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTBlood samplelongitudinal blood samples for CTC monitoring
DEVICEMRI scanlongitudinal MRI scans (non-contrast enhanced)

Timeline

Start date
2022-11-30
Primary completion
2026-01-31
Completion
2030-09-30
First posted
2022-09-01
Last updated
2025-09-08

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT05524012. Inclusion in this directory is not an endorsement.